首页 > 最新文献

QJM: An International Journal of Medicine最新文献

英文 中文
An Ominous 'Halo'- Extensive Pulmonary Metastases from a Hepatic Angiosarcoma.
IF 7.3 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-21 DOI: 10.1093/qjmed/hcaf053
Sreedhar Jayakrishnan Cherulil, Sreelesh Kp, Ramakrishnan Kg
{"title":"An Ominous 'Halo'- Extensive Pulmonary Metastases from a Hepatic Angiosarcoma.","authors":"Sreedhar Jayakrishnan Cherulil, Sreelesh Kp, Ramakrishnan Kg","doi":"10.1093/qjmed/hcaf053","DOIUrl":"https://doi.org/10.1093/qjmed/hcaf053","url":null,"abstract":"","PeriodicalId":20806,"journal":{"name":"QJM: An International Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143468980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The differential diagnosis of scurvy.
IF 7.3 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-20 DOI: 10.1093/qjmed/hcaf047
Hung-Kai Lo, Po-Jen Hsiao
{"title":"The differential diagnosis of scurvy.","authors":"Hung-Kai Lo, Po-Jen Hsiao","doi":"10.1093/qjmed/hcaf047","DOIUrl":"https://doi.org/10.1093/qjmed/hcaf047","url":null,"abstract":"","PeriodicalId":20806,"journal":{"name":"QJM: An International Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel model for identifying infections in patients with acute-on-chronic liver disease (AoCLD): A nationwide, multicenter, prospective cohort study.
IF 7.3 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-20 DOI: 10.1093/qjmed/hcaf052
Hui Zhou, Hai Li, Guohong Deng, Xianbo Wang, Xin Zheng, Jinjun Chen, Zhongji Meng, Yubao Zheng, Yanhang Gao, Zhiping Qian, Feng Liu, Xiaobo Lu, Yu Shi, Jia Shang, Yan Huang, Ruochan Chen

Background and aims: To establish an early and quick model for diagnosing infections in patients with acute-on-chronic liver disease (AoCLD).

Approach: This study analyzed 3,949 patients from two multicenter prospective cohorts of the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study. The dataset was randomly divided into training and validation cohorts in a 7:3 ratio. In the training cohort, logistic regression and least absolute shrinkage and selection operator regression analyses were used to identify predictive risk factors for infection in patients with AoCLD, and a simple nomogram was established. Two different cutoff values were determined to stratify infection risk in AoCLD patients.

Results: The developed diagnostic model included six variables: cirrhosis, ascites, neutrophil count (N), and total bilirubin, C-reactive protein (CRP), and blood sodium levels. The area under the receiver operating characteristic curve for the training and validation cohorts were 0.818 and 0.809, respectively, significantly higher than using CRP, procalcitonin, or N alone. Additionally, in the training cohort, we set a low cutoff value of 0.2028, resulting in a sensitivity of 80.15%, specificity of 68.25%, and a negative predictive value of 92.7% for rule-out diagnosis. A high cutoff value of 0.4045 resulting in a specificity of 90.1%, sensitivity of 52.7%, and a positive predictive value of 64% for rule-in diagnosis. These cutoff values were validated in the validation cohort.

Conclusions: We established a nomogram model to assist clinicians in diagnosing infections in patients with AoCLD, effectively improving the accuracy and timeliness of diagnosis.

{"title":"A novel model for identifying infections in patients with acute-on-chronic liver disease (AoCLD): A nationwide, multicenter, prospective cohort study.","authors":"Hui Zhou, Hai Li, Guohong Deng, Xianbo Wang, Xin Zheng, Jinjun Chen, Zhongji Meng, Yubao Zheng, Yanhang Gao, Zhiping Qian, Feng Liu, Xiaobo Lu, Yu Shi, Jia Shang, Yan Huang, Ruochan Chen","doi":"10.1093/qjmed/hcaf052","DOIUrl":"https://doi.org/10.1093/qjmed/hcaf052","url":null,"abstract":"<p><strong>Background and aims: </strong>To establish an early and quick model for diagnosing infections in patients with acute-on-chronic liver disease (AoCLD).</p><p><strong>Approach: </strong>This study analyzed 3,949 patients from two multicenter prospective cohorts of the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study. The dataset was randomly divided into training and validation cohorts in a 7:3 ratio. In the training cohort, logistic regression and least absolute shrinkage and selection operator regression analyses were used to identify predictive risk factors for infection in patients with AoCLD, and a simple nomogram was established. Two different cutoff values were determined to stratify infection risk in AoCLD patients.</p><p><strong>Results: </strong>The developed diagnostic model included six variables: cirrhosis, ascites, neutrophil count (N), and total bilirubin, C-reactive protein (CRP), and blood sodium levels. The area under the receiver operating characteristic curve for the training and validation cohorts were 0.818 and 0.809, respectively, significantly higher than using CRP, procalcitonin, or N alone. Additionally, in the training cohort, we set a low cutoff value of 0.2028, resulting in a sensitivity of 80.15%, specificity of 68.25%, and a negative predictive value of 92.7% for rule-out diagnosis. A high cutoff value of 0.4045 resulting in a specificity of 90.1%, sensitivity of 52.7%, and a positive predictive value of 64% for rule-in diagnosis. These cutoff values were validated in the validation cohort.</p><p><strong>Conclusions: </strong>We established a nomogram model to assist clinicians in diagnosing infections in patients with AoCLD, effectively improving the accuracy and timeliness of diagnosis.</p>","PeriodicalId":20806,"journal":{"name":"QJM: An International Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143468977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A United Kingdom nationally representative survey of public attitudes towards pharmacogenomics.
IF 7.3 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-20 DOI: 10.1093/qjmed/hcaf035
Emma F Magavern, Gabriel Marengo, Chujan Sivathasan, Marta Mezzanzanica, Alison J Wright, Jessica Keen, Videha Sharma, John H McDermott, Claire Duckett, Dave McCormick, Shelley Simmonds, Emma Walters, John Weinman, Vivienne Parry, William G Newman, Mark J Caulfield

Background: Variation in DNA is known to contribute to medication response, impacting both medicine effectiveness and incidence of adverse drug reactions (ADRs). However, clinical implementation of pharmacogenomics (PGx) has been slow, and the views of the public are not well understood.

Aim: To assess UK national public attitudes around pharmacogenetics.

Design and methods: The survey was co-designed with the Participant Panel at Genomics England and the data were collected by the National Centre for Social Research, using its nationally representative panel of UK adults. Multivariable logistic regression analyses were used to analyse relationships between selected survey reported variables, controlled for age and sex.

Results: The survey response rate was 58%. Two thousand seven hundred and nineteen responses were obtained. Most respondents (59%) had experienced either no benefit or a side effect. Forty-five per cent of respondents reported having experienced no benefit and 46% of respondents reported having experienced a side effect, with female respondents more likely to be in both groups (P < 0.0001). Despite variability in interindividual medicine response being well understood (89%), the involvement of DNA in predicting benefit or risk of a side effect is not (understood by 52% and 48%, respectively). Eighty-nine per cent would complete a PGx test, with 91% wanting direct access to this information. Eighty-five per cent of UK adults think that the NHS should offer PGx to those regularly taking many medicines. Respondents were not more worried overall about misuse of PGx data compared with other routine medical data. Experience with prescription medication impacted on views with those who were prescribed medication almost twice as likely to want a PGx test for any reason.

Conclusion: Most respondents reported experience with either a medication not working for them or ADRs. There was a high level of understanding of variable medication response but a relatively low level of awareness of the role genetics plays in that variability. Most respondents would want a PGx test, to have direct access to results, and think the NHS should offer this form of testing. Importantly, respondents were not more concerned about PGx data use than that of any other routinely generated medical data. Notably, this study highlights a relationship between individuals' experiences with prescription medications and their interest in PGx testing, underscoring the potential for personalized medicine to address public healthcare needs.

{"title":"A United Kingdom nationally representative survey of public attitudes towards pharmacogenomics.","authors":"Emma F Magavern, Gabriel Marengo, Chujan Sivathasan, Marta Mezzanzanica, Alison J Wright, Jessica Keen, Videha Sharma, John H McDermott, Claire Duckett, Dave McCormick, Shelley Simmonds, Emma Walters, John Weinman, Vivienne Parry, William G Newman, Mark J Caulfield","doi":"10.1093/qjmed/hcaf035","DOIUrl":"https://doi.org/10.1093/qjmed/hcaf035","url":null,"abstract":"<p><strong>Background: </strong>Variation in DNA is known to contribute to medication response, impacting both medicine effectiveness and incidence of adverse drug reactions (ADRs). However, clinical implementation of pharmacogenomics (PGx) has been slow, and the views of the public are not well understood.</p><p><strong>Aim: </strong>To assess UK national public attitudes around pharmacogenetics.</p><p><strong>Design and methods: </strong>The survey was co-designed with the Participant Panel at Genomics England and the data were collected by the National Centre for Social Research, using its nationally representative panel of UK adults. Multivariable logistic regression analyses were used to analyse relationships between selected survey reported variables, controlled for age and sex.</p><p><strong>Results: </strong>The survey response rate was 58%. Two thousand seven hundred and nineteen responses were obtained. Most respondents (59%) had experienced either no benefit or a side effect. Forty-five per cent of respondents reported having experienced no benefit and 46% of respondents reported having experienced a side effect, with female respondents more likely to be in both groups (P < 0.0001). Despite variability in interindividual medicine response being well understood (89%), the involvement of DNA in predicting benefit or risk of a side effect is not (understood by 52% and 48%, respectively). Eighty-nine per cent would complete a PGx test, with 91% wanting direct access to this information. Eighty-five per cent of UK adults think that the NHS should offer PGx to those regularly taking many medicines. Respondents were not more worried overall about misuse of PGx data compared with other routine medical data. Experience with prescription medication impacted on views with those who were prescribed medication almost twice as likely to want a PGx test for any reason.</p><p><strong>Conclusion: </strong>Most respondents reported experience with either a medication not working for them or ADRs. There was a high level of understanding of variable medication response but a relatively low level of awareness of the role genetics plays in that variability. Most respondents would want a PGx test, to have direct access to results, and think the NHS should offer this form of testing. Importantly, respondents were not more concerned about PGx data use than that of any other routinely generated medical data. Notably, this study highlights a relationship between individuals' experiences with prescription medications and their interest in PGx testing, underscoring the potential for personalized medicine to address public healthcare needs.</p>","PeriodicalId":20806,"journal":{"name":"QJM: An International Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Correspondence to Short and Long-Term Mortality Following Acute Medical Admission.
IF 7.3 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-18 DOI: 10.1093/qjmed/hcae220
Richard Conway, Declan Byrne, Deirdre O'Riordan, Bernard Silke
{"title":"Response to Correspondence to Short and Long-Term Mortality Following Acute Medical Admission.","authors":"Richard Conway, Declan Byrne, Deirdre O'Riordan, Bernard Silke","doi":"10.1093/qjmed/hcae220","DOIUrl":"https://doi.org/10.1093/qjmed/hcae220","url":null,"abstract":"","PeriodicalId":20806,"journal":{"name":"QJM: An International Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143449661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Intravenous Laser Irradiation of Blood on Cognitive Function and Molecular Pathways in Long COVID Patients: A Pilot Study.
IF 7.3 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-17 DOI: 10.1093/qjmed/hcaf050
Cheng-Chiang Chang, Yu-He Li, Shin-Tsu Chang, Hsin-Hung Chen

Background: Long COVID presents persistent neurological symptoms, including brain fog, with limited therapeutic options. Intravenous Laser Irradiation of Blood (ILIB) has been proposed as a potential intervention. This pilot study explores the efficacy of ILIB in alleviating brain fog symptoms and examines the underlying molecular mechanisms.

Aim: To evaluate the effectiveness of ILIB in improving cognitive function in long COVID patients with brain fog and to investigate the molecular pathways involved.

Design: A prospective, single-center pilot study involving six long COVID patients with brain fog who underwent ILIB therapy.

Methods: Patients received 30 ILIB sessions over eight weeks. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), and Athens Insomnia Scale (AIS) at baseline, post-treatment, and one-month follow-up. RNA sequencing and pathway enrichment analyses (KEGG, Gene Ontology) identified differentially expressed genes and molecular pathways influenced by ILIB.

Results: MoCA and AIS scores significantly improved post-ILIB, suggesting enhanced cognitive function and sleep quality. RNA sequencing revealed 141 upregulated and 130 downregulated genes. Upregulated pathways were associated with mitochondrial electron transport and oxidative phosphorylation, while immune response and inflammatory pathways were downregulated. Notably, the glutathione metabolism pathway was significantly altered, suggesting reduced oxidative stress.

Conclusions: ILIB shows potential in alleviating brain fog symptoms in long COVID patients, possibly through modulation of oxidative stress, mitochondrial function, and inflammation. However, larger randomized controlled trials are needed to confirm these findings and establish ILIB as a viable therapeutic option.

{"title":"Impact of Intravenous Laser Irradiation of Blood on Cognitive Function and Molecular Pathways in Long COVID Patients: A Pilot Study.","authors":"Cheng-Chiang Chang, Yu-He Li, Shin-Tsu Chang, Hsin-Hung Chen","doi":"10.1093/qjmed/hcaf050","DOIUrl":"https://doi.org/10.1093/qjmed/hcaf050","url":null,"abstract":"<p><strong>Background: </strong>Long COVID presents persistent neurological symptoms, including brain fog, with limited therapeutic options. Intravenous Laser Irradiation of Blood (ILIB) has been proposed as a potential intervention. This pilot study explores the efficacy of ILIB in alleviating brain fog symptoms and examines the underlying molecular mechanisms.</p><p><strong>Aim: </strong>To evaluate the effectiveness of ILIB in improving cognitive function in long COVID patients with brain fog and to investigate the molecular pathways involved.</p><p><strong>Design: </strong>A prospective, single-center pilot study involving six long COVID patients with brain fog who underwent ILIB therapy.</p><p><strong>Methods: </strong>Patients received 30 ILIB sessions over eight weeks. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), and Athens Insomnia Scale (AIS) at baseline, post-treatment, and one-month follow-up. RNA sequencing and pathway enrichment analyses (KEGG, Gene Ontology) identified differentially expressed genes and molecular pathways influenced by ILIB.</p><p><strong>Results: </strong>MoCA and AIS scores significantly improved post-ILIB, suggesting enhanced cognitive function and sleep quality. RNA sequencing revealed 141 upregulated and 130 downregulated genes. Upregulated pathways were associated with mitochondrial electron transport and oxidative phosphorylation, while immune response and inflammatory pathways were downregulated. Notably, the glutathione metabolism pathway was significantly altered, suggesting reduced oxidative stress.</p><p><strong>Conclusions: </strong>ILIB shows potential in alleviating brain fog symptoms in long COVID patients, possibly through modulation of oxidative stress, mitochondrial function, and inflammation. However, larger randomized controlled trials are needed to confirm these findings and establish ILIB as a viable therapeutic option.</p>","PeriodicalId":20806,"journal":{"name":"QJM: An International Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143441607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trichophyton Mentagrophytes type VII (TMVII): an emerging sexually transmitted pathogen.
IF 7.3 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-14 DOI: 10.1093/qjmed/hcaf049
R Kapranou, O Kotsafti, G Vrioni, A Giannoukos, S Papanikou, A Stratigos, E Nicolaidou
{"title":"Trichophyton Mentagrophytes type VII (TMVII): an emerging sexually transmitted pathogen.","authors":"R Kapranou, O Kotsafti, G Vrioni, A Giannoukos, S Papanikou, A Stratigos, E Nicolaidou","doi":"10.1093/qjmed/hcaf049","DOIUrl":"https://doi.org/10.1093/qjmed/hcaf049","url":null,"abstract":"","PeriodicalId":20806,"journal":{"name":"QJM: An International Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143415029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coca-Cola bottle sign in thyroid-associated ophthalmopathy.
IF 7.3 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-14 DOI: 10.1093/qjmed/hcaf046
Chun-Hsiang Chang, Chun-Chieh Lai
{"title":"Coca-Cola bottle sign in thyroid-associated ophthalmopathy.","authors":"Chun-Hsiang Chang, Chun-Chieh Lai","doi":"10.1093/qjmed/hcaf046","DOIUrl":"https://doi.org/10.1093/qjmed/hcaf046","url":null,"abstract":"","PeriodicalId":20806,"journal":{"name":"QJM: An International Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143415028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early acupuncture intervention for pain relief in emergency department patients with suspected acute renal colic caused by urinary calculi: A randomized clinical trial.
IF 7.3 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-13 DOI: 10.1093/qjmed/hcaf011
Ying Cao, Zhicheng Qu, Shuwen Zhang, Yunhua Liu, Liancheng Jia, Xiaolu Pei, Xiao Wang, Dantong Zhang, Binyan Li, Haitian Lu, Maoyu Ding, Yinglu Bai, Shuang Wang, Yufei Yang, Jing Hu, Wei Peng, Wei Guo, Xiaolong Xu, Qingquan Liu

Background: Renal colic is one of the worst types of pain in acute renal colic caused by urinary calculi (ARCUC). We previously proved that acupuncture can alleviate the pain in ARCUC patients, but its effect on suspected ARCUC remains unclear.

Objective: The objective was to evaluate the effectiveness and safety of acupuncture in patients with suspected ARCUC.

Design: This prospective, double-blind, sham acupuncture-controlled, randomized clinical trial was conducted from July 2021 to June 2024 in an emergency department in China.

Methods: The patients immediately received acupuncture treatment or sham acupuncture treatment after randomization.The primary outcome was the response rate at 10 minutes (pain relief rate) after needle manipulation.The secondary outcomes included the response rates at 0, 5, 15, 20, and 30 minutes, trends in the NRS score over time, patient satisfaction, the analgesic injection rate at 30 minutes, the surgical intervention rate, the revisit rate, and the occurrence of adverse events.

Results: This trial enrolled 84 participants with suspected ARCUC patients, who immediately received acupuncture treatment or sham treatment after randomization. The pain response rates at 10 minutes were 64.3% and 16.7% in the acupuncture group and sham group, respectively, and the difference between the groups was 47.6% (95% CI, 29.3% to 66%; P < 0.01). The response rates of acupuncture were also significantly higher than those of sham acupuncture at 0, 5, 15, 20, and 30 minutes.

Conclusions: These results suggest that acupuncture could alleviate the pain in patients with suspected ARCUC safely.

Trial registration: Chinese Clinical Trial Registry: ChiCTR2100049069.

{"title":"Early acupuncture intervention for pain relief in emergency department patients with suspected acute renal colic caused by urinary calculi: A randomized clinical trial.","authors":"Ying Cao, Zhicheng Qu, Shuwen Zhang, Yunhua Liu, Liancheng Jia, Xiaolu Pei, Xiao Wang, Dantong Zhang, Binyan Li, Haitian Lu, Maoyu Ding, Yinglu Bai, Shuang Wang, Yufei Yang, Jing Hu, Wei Peng, Wei Guo, Xiaolong Xu, Qingquan Liu","doi":"10.1093/qjmed/hcaf011","DOIUrl":"https://doi.org/10.1093/qjmed/hcaf011","url":null,"abstract":"<p><strong>Background: </strong>Renal colic is one of the worst types of pain in acute renal colic caused by urinary calculi (ARCUC). We previously proved that acupuncture can alleviate the pain in ARCUC patients, but its effect on suspected ARCUC remains unclear.</p><p><strong>Objective: </strong>The objective was to evaluate the effectiveness and safety of acupuncture in patients with suspected ARCUC.</p><p><strong>Design: </strong>This prospective, double-blind, sham acupuncture-controlled, randomized clinical trial was conducted from July 2021 to June 2024 in an emergency department in China.</p><p><strong>Methods: </strong>The patients immediately received acupuncture treatment or sham acupuncture treatment after randomization.The primary outcome was the response rate at 10 minutes (pain relief rate) after needle manipulation.The secondary outcomes included the response rates at 0, 5, 15, 20, and 30 minutes, trends in the NRS score over time, patient satisfaction, the analgesic injection rate at 30 minutes, the surgical intervention rate, the revisit rate, and the occurrence of adverse events.</p><p><strong>Results: </strong>This trial enrolled 84 participants with suspected ARCUC patients, who immediately received acupuncture treatment or sham treatment after randomization. The pain response rates at 10 minutes were 64.3% and 16.7% in the acupuncture group and sham group, respectively, and the difference between the groups was 47.6% (95% CI, 29.3% to 66%; P < 0.01). The response rates of acupuncture were also significantly higher than those of sham acupuncture at 0, 5, 15, 20, and 30 minutes.</p><p><strong>Conclusions: </strong>These results suggest that acupuncture could alleviate the pain in patients with suspected ARCUC safely.</p><p><strong>Trial registration: </strong>Chinese Clinical Trial Registry: ChiCTR2100049069.</p>","PeriodicalId":20806,"journal":{"name":"QJM: An International Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143410167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Motile trophozoites in Granulomatous Amoebic Encephalitis.
IF 7.3 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-13 DOI: 10.1093/qjmed/hcaf048
Nitin Gupta, Pothumarthy Venkata Swathi Kiran, Vinay Khanna, Sumeeta Khurana, Muralidhar Varma, Tirlangi Praveen Kumar
{"title":"Motile trophozoites in Granulomatous Amoebic Encephalitis.","authors":"Nitin Gupta, Pothumarthy Venkata Swathi Kiran, Vinay Khanna, Sumeeta Khurana, Muralidhar Varma, Tirlangi Praveen Kumar","doi":"10.1093/qjmed/hcaf048","DOIUrl":"https://doi.org/10.1093/qjmed/hcaf048","url":null,"abstract":"","PeriodicalId":20806,"journal":{"name":"QJM: An International Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143410206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
QJM: An International Journal of Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1